2024
DOI: 10.1016/j.celrep.2024.113834
|View full text |Cite
|
Sign up to set email alerts
|

GABA co-released from striatal dopamine axons dampens phasic dopamine release through autoregulatory GABAA receptors

Jyoti C. Patel,
Ang D. Sherpa,
Riccardo Melani
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 138 publications
(220 reference statements)
0
0
0
Order By: Relevance
“…The striatum is a predominantly GABAergic structure consisting of mostly GABAergic medium spiny neurons along with a variety of GABAergic interneurons, each with a unique connectivity pattern to the surrounding circuitry (Taverna et al, 2008; Dobbs et al, 2016; Tepper et al, 2018; Dorst et al, 2020; Holly et al, 2021; Kocaturk et al, 2022). As a result, there are many possible sources of GABA within the striatum, including these GABAergic neurons, non-neuronal cells, co-release from DA axons, and co-release from CINs – any combination of which could be contributing to the effects observed here (Tritsch et al, 2012; Wójtowicz et al, 2013; Lozovaya et al, 2018; Roberts et al, 2020; Patel et al, 2024). Recently, Patel and colleagues showed that GABA co-released from DA axons can inhibit the same axons via autoregulatory GABA A receptors (Patel et al, 2024).…”
Section: Discussionmentioning
confidence: 98%
See 2 more Smart Citations
“…The striatum is a predominantly GABAergic structure consisting of mostly GABAergic medium spiny neurons along with a variety of GABAergic interneurons, each with a unique connectivity pattern to the surrounding circuitry (Taverna et al, 2008; Dobbs et al, 2016; Tepper et al, 2018; Dorst et al, 2020; Holly et al, 2021; Kocaturk et al, 2022). As a result, there are many possible sources of GABA within the striatum, including these GABAergic neurons, non-neuronal cells, co-release from DA axons, and co-release from CINs – any combination of which could be contributing to the effects observed here (Tritsch et al, 2012; Wójtowicz et al, 2013; Lozovaya et al, 2018; Roberts et al, 2020; Patel et al, 2024). Recently, Patel and colleagues showed that GABA co-released from DA axons can inhibit the same axons via autoregulatory GABA A receptors (Patel et al, 2024).…”
Section: Discussionmentioning
confidence: 98%
“…As a result, there are many possible sources of GABA within the striatum, including these GABAergic neurons, non-neuronal cells, co-release from DA axons, and co-release from CINs -any combination of which could be contributing to the effects observed here (Tritsch et al, 2012;Wójtowicz et al, 2013;Lozovaya et al, 2018;Roberts et al, 2020;Patel et al, 2024). Recently, Patel and colleagues showed that GABA co-released from DA axons can inhibit the same axons via autoregulatory GABAA receptors (Patel et al, 2024). Together with the data presented here and past results showing that CINs can drive GABA release from DA axons (Nelson et al, 2014), this feature could endow the CIN-DA axon striatal circuit with a complex means of intrinsic negative feedback.…”
Section: Gabaergic Control Over Da Axon Excitabilitymentioning
confidence: 99%
See 1 more Smart Citation
“…It is possible that not GABA but another inhibitory transmitter is packaged into vesicles by VMAT2 and responsible for the activation of postsynaptic striatal GABAA receptors that was reported after optogenetic stimulation of DA terminals (Melani et al, 2022;Patel et al, 2024;Tritsch et al, 2012;Tritsch et al, 2014). We tested two such potential compounds in the mouse vesicle uptake, glycine and taurine, both of which are structural analogues of GABA that have been reported to activate GABAA receptors, though presumably with much weaker affinity (Jonas et al, 1998).…”
Section: Effects Of Glycine and Taurine On Vmat2mentioning
confidence: 99%